CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Medical Officer sold 7,433 shares at $18.75 ($139,369)
- 4 Option exercise Chief Financial Officer acquired 3,541 shares (option exercise)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 4 Option exercise Chief Financial Officer acquired 3,542 shares (option exercise)
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale Chief Financial Officer sold 27,000 shares at an average $19.70 ($531,828)
- 4 Planned sale Chief Executive Officer sold 233,107 shares at $18.12 ($4,223,036)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale Chief Medical Officer sold 7,433 shares at $12.85 ($95,490)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 18,000 shares at $12.00 ($216,000)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 68,897 shares at $10.19 ($701,909)
Page 3 of 8 · 157 filings